====== Citral 75μM R06 exp275 ====== ==== Mechanism of Action ==== putative ALDH inhibitor, essential oil * **Class / Subclass 1:** Uncharacterized Mechanism / Natural Product * **Class / Subclass 2:** Metabolism / Metabolic Enzyme Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%Citral%% * **Synonyms:** N/A * **CAS #:** 5392-40-5 * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/638011|638011]] * **IUPAC:** %%(2E)-3,7-dimethylocta-2,6-dienal%% * **INCHI Name:** InChI=1S/C10H16O/c1-9(2)5-4-6-10(3)7-8-11/h5,7-8H,4,6H2,1-3H3/b10-7+ * **INCHI Key:** WTEVQBCEXWBHNA-JXMROGBWSA-N * **Molecular Weight:** 152.23 * **Canonical SMILES:** CC(=CCCC(=CC=O)C)C * **Isomeric SMILES:** CC(=CCC/C(=C/C=O)/C)C * **Molecular Formula:** C10H16O {{:chemogenomics:structures:chem-0166.svg?nolink}} * **Supplier Name:** Sigma-Aldrich * **Catalog #:** C83007 * **Lot #:** MKBL6233V * **LCMS:** Tr 1.23 min, m/z 135+ [M+H-H2O]+. * **Platform ID:** Citral * **Min:** -22.4332; **Max:** 72.2322 {{:chemogenomics:dose_response:dr_283.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |N/A | | IC20 |N/A | | IC30 |N/A | | IC40 |N/A | | IC50 |N/A | | IC60 |N/A | | IC70 |N/A | | IC80 |N/A | | IC90 |N/A | \\ ==== Screen Summary ==== * **Round**: 06 * **Dose**: 75µM * **Days of incubation**: 8 * **Doublings**: 1.4 * **Numbers of reads**: 8529157 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |3/14|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/Citral_75uM_Round-6_exp275.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp275.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:T:TCF4|TCF4]]|-3.32|<0.01| |[[:human_genes:P:PRKAA1|PRKAA1]]|-3.02|<0.01| |[[:human_genes:M:MTCH2|MTCH2]]|-2.84|0.05| |[[:human_genes:A:ABCC1|ABCC1]]|-2.70|0.07| |[[:human_genes:X:XPR1|XPR1]]|-2.47|0.08| |[[:human_genes:R:RHOA|RHOA]]|-2.41|0.11| |[[:human_genes:D:DPRX|DPRX]]|-2.39|0.11| |[[:human_genes:C:CSK|CSK]]|-2.33|0.21| |[[:human_genes:R:RAB24|RAB24]]|-2.25|0.21| |[[:human_genes:T:TRIP12|TRIP12]]|-2.23|0.21| |[[:human_genes:P:PRKAG1|PRKAG1]]|-2.23|0.37| |[[:human_genes:G:GABARAP|GABARAP]]|-2.20|0.21| |[[:human_genes:M:MEIG1|MEIG1]]|-2.13|0.49| |[[:human_genes:A:ANAPC15|ANAPC15]]|-2.09|0.37| |[[:human_genes:C:CYLD|CYLD]]|-2.08|0.37| |[[:human_genes:T:TRIM44|TRIM44]]|-2.07|0.37| |[[:human_genes:N:NPRL3|NPRL3]]|-2.07|0.48| |[[:human_genes:C:C11orf30|C11orf30]]|-2.06|0.37| |[[:human_genes:H:HIST1H3E|HIST1H3E]]|-2.06|0.37| |[[:human_genes:T:TBC1D17|TBC1D17]]|-2.04|0.37| |[[:human_genes:G:GPR21|GPR21]]|-2.03|0.37| |[[:human_genes:C:CFLAR|CFLAR]]|-2.03|0.37| |[[:human_genes:G:GPBP1|GPBP1]]|-2.02|0.37| |[[:human_genes:S:SLC9A8|SLC9A8]]|-2.02|0.37| |[[:human_genes:F:FBXL5|FBXL5]]|-1.98|0.37| |[[:human_genes:G:GIGYF2|GIGYF2]]|-1.96|0.48| |[[:human_genes:S:SLC16A5|SLC16A5]]|-1.96|0.37| |[[:human_genes:M:MORF4L1|MORF4L1]]|-1.95|0.37| |[[:human_genes:S:SEPHS2|SEPHS2]]|-1.95|0.37| |[[:human_genes:C:CXCR4|CXCR4]]|-1.95|0.37| |[[:human_genes:R:RICTOR|RICTOR]]|2.24|0.08| |[[:human_genes:A:ALAD|ALAD]]|2.24|0.15| |[[:human_genes:S:SLC7A1|SLC7A1]]|2.24|0.26| |[[:human_genes:Z:ZBTB18|ZBTB18]]|2.25|0.08| |[[:human_genes:E:EIF3B|EIF3B]]|2.26|0.34| |[[:human_genes:F:FGFR4|FGFR4]]|2.27|0.07| |[[:human_genes:S:SIX2|SIX2]]|2.28|0.12| |[[:human_genes:D:DPH5|DPH5]]|2.31|0.06| |[[:human_genes:E:EIF3A|EIF3A]]|2.37|0.05| |[[:human_genes:T:TRMT61A|TRMT61A]]|2.39|0.21| |[[:human_genes:P:PDS5B|PDS5B]]|2.42|0.04| |[[:human_genes:D:DRG1|DRG1]]|2.46|0.06| |[[:human_genes:M:METTL1|METTL1]]|2.49|0.05| |[[:human_genes:A:AP1M1|AP1M1]]|2.49|0.03| |[[:human_genes:D:DAO|DAO]]|2.51|0.05| |[[:human_genes:M:METTL21D|METTL21D]]|2.55|0.03| |[[:human_genes:A:ATP5B|ATP5B]]|2.58|0.04| |[[:human_genes:N:NHP2L1|NHP2L1]]|2.65|0.18| |[[:human_genes:H:HSD17B12|HSD17B12]]|2.69|0.05| |[[:human_genes:P:PIK3CD|PIK3CD]]|2.71|0.02| |[[:human_genes:C:CD19|CD19]]|2.75|0.02| |[[:human_genes:D:DPH2|DPH2]]|2.76|0.02| |[[:human_genes:A:ACSL3|ACSL3]]|2.83|0.02| |[[:human_genes:M:MIDN|MIDN]]|2.85|<0.01| |[[:human_genes:H:HMHA1|HMHA1]]|2.96|0.02| |[[:human_genes:A:ATPAF2|ATPAF2]]|3.18|<0.01| |[[:human_genes:R:RBM26|RBM26]]|3.22|<0.01| |[[:human_genes:L:LRRC63|LRRC63]]|3.37|0.18| |[[:human_genes:A:ATP5A1|ATP5A1]]|3.69|<0.01| |[[:human_genes:P:PRRC2C|PRRC2C]]|3.87|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.076|| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.069|| |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|0.061|| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|0.058|| |[[:results:exp234|Ethanol 0.01 R05 exp234]]|0.054|| |[[:results:exp431|Rotenone 0.07μM R08 exp431]]|0.053|| |[[:results:exp445|∆-9-Tetrahydrocannabinol 30μM R08 exp445]]|0.053|| |[[:results:exp102|Nifuroxazide 5μM R03 exp102]]|0.053|| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|0.052|| |[[:results:exp274|Citral 50μM R06 exp274]]|0.078|| |[[:results:exp466|Cannabidiol 20μM R08 exp466]]|0.07|| |[[:results:exp334|All-trans-Retinoic-Acid 40μM R07 exp334]]|0.069|| |[[:results:exp447|Amiloride 100μM R08 exp447]]|0.053|| |[[:results:exp269|Bisphenol A 100μM R06 exp269]]|0.051|| {{:chemogenomics:comparison_plots:exp275_vs_exp488.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp489.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp535.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp439.png?nolink |}} {{:chemogenomics:comparison_plots:exp234_vs_exp275.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp431.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp445.png?nolink |}} {{:chemogenomics:comparison_plots:exp102_vs_exp275.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp526.png?nolink |}} {{:chemogenomics:comparison_plots:exp274_vs_exp275.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp466.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp334.png?nolink |}} {{:chemogenomics:comparison_plots:exp275_vs_exp447.png?nolink |}} {{:chemogenomics:comparison_plots:exp269_vs_exp275.png?nolink |}} ^GO Term^Fold Change^Genes^ |proline-rich region binding|119.51|CSK,CYLD,GIGYF2| ^GO Term^Fold Change^Genes^ |angiostatin binding|368.27|ATP5F1A,ATP5F1B| |proton-transporting ATP synthase complex, catalytic core F(1)|331.44|ATP5F1A,ATP5F1B,ATP5PO| |mitochondrial proton-transporting ATP synthase complex, catalytic sector F(1)|276.20|ATP5F1A,ATP5F1B| |proton-transporting ATP synthase activity, rotational mechanism|118.37|ATP5F1A,ATP5F1B,ATP5PO| |mitochondrial proton-transporting ATP synthase complex|110.48|ATP5F1A,ATP5F1B,ATP5PO| |proton-transporting two-sector ATPase complex, catalytic domain|97.48|ATP5F1A,ATP5F1B,ATP5PO| |purine ribonucleotide biosynthetic process|15.78|ATP5F1A,ACSL3,HSD17B12,ATP5F1B,ATP5PO|